Fundraising FoxEsperance Pharmaceuticals
Houston, US · 2 known investors
Find your way into Esperance Pharmaceuticals
Sign up to see every warm intro you have to Esperance Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Esperance Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Esperance develops targeted oncology therapeutics designed to selectively kill cancer cells, including chemotherapy-resistant cells, via a proprietary Cationic Lytic Peptide (CLYP) platform, membrane-disrupting peptides, and antibody drug conjugates. The company operates from Houston, Texas near the Texas Medical Center, with MD Anderson Cancer Center as a strategic partner.
Founders & leadership
HA
Hector AlilaNamed on SEC filing
RB
Ross BarrettNamed on SEC filing
PH
Peter HoangNamed on SEC filing
SD
Sonia DeggsNamed on SEC filing
CL
Carola LeuschnerNamed on SEC filing
Board
JL
Investors · 2
Reported raises · per SEC filings
Form D private placements$1M disclosed across 1 round · 2019
▶$1MraisedJul 2019 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedJul 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hector AlilaExecutive Officer, Director
- Ross BarrettDirector
- Joseph LovettDirector
- Peter HoangDirector
- Sonia DeggsExecutive Officer
- Carola LeuschnerExecutive Officer
- Offering amount
- $1M
- Amount sold
- $1M
- Proceeds to insiders
- $100K
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Esperance Pharmaceuticals do?
- Esperance develops targeted oncology therapeutics designed to selectively kill cancer cells, including chemotherapy-resistant cells, via a proprietary Cationic Lytic Peptide (CLYP) platform, membrane-disrupting peptides, and antibody drug conjugates. The company operates from Houston, Texas near the Texas Medical Center, with MD Anderson Cancer Center as a strategic partner.
- Who are Esperance Pharmaceuticals's investors?
- Esperance Pharmaceuticals's investors include Research Corporation Technologies, Louisiana Funds.
- How much funding has Esperance Pharmaceuticals raised?
- Esperance Pharmaceuticals has disclosed $1M raised across 1 round.
- Where is Esperance Pharmaceuticals headquartered?
- Esperance Pharmaceuticals is headquartered in Houston, US.